[Studies on the action of MTDQ - 6,6'-methylene bis (2,2,4-trimethyl-1,2-dihydroquinoline) on the growth of murine mammary cancer, survival rate of V-79 cells and DNA biosynthesis of L5178 Y cells].
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D006224:Cricetinae; D003412:Cricetulus; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004353:Drug Evaluation, Preclinical; D005260:Female; D007940:Leukemia L5178 / Q000473:pathology; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D051379:Mice; D011804:Quinolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D011804:Quinolines; C011923:6,6'-methylene bis(2,2,4-trimethyl-1,2-dihydroquinoline)
Untersuchungen zur Wirkung von MTDQ-6,6'-Methylen-bis(2,2,4-Trimethyl-1,2-Dihydroquinolin) auf das Wachstum des Mammakarzinoms der Maus, die Uberlebensrate von V-79-Zellen und die DNS-Syntheses von L5178 Y-Zellen.